Life Sciences

Researchers propose combining blood biopsies with genetic mutation analysis to catch tumors earlier and match patients to treatments more precisely. The approach could unlock personalized cancer care for patients whose tumors lack known drug targets—potentially opening new markets for diagnostics and expanding treatment options across solid tumors.EN

Researchers have validated a simple blood-based technique for detecting calprotectin, a marker of airway inflammation, in sputum samples from patients with chronic lung disease. The finding could enable faster, more reliable diagnosis and monitoring of conditions like COPD and cystic fibrosis, potentially reducing hospital visits and treatment delays.EN

Researchers have created an automated system to dissect PROTACs—complex molecules designed to destroy disease-causing proteins—a task that previously required months of manual work. The breakthrough could accelerate drug discovery by years, though early versions struggle with truly novel molecular designs.EN

A new computational method reveals that conventional protein analysis systematically underestimates how actively enzymes break down proteins in cells. The technique could improve drug development, disease diagnostics, and efforts to engineer cells for manufacturing, by finally giving researchers an accurate picture of what's actually happening inside living systems.EN

Researchers have identified a previously unknown type of neutrophil that appears in psoriasis lesions triggered by strep throat, suggesting the immune response to infection may directly drive skin disease. The finding could reshape how companies develop therapies and help clinicians predict which patients will develop the condition after infection.EN

Researchers have released Nallo, an open-source software pipeline that streamlines analysis of long-read DNA sequencing data—a technology increasingly used to diagnose rare genetic diseases. The tool automates what previously required significant manual work, potentially accelerating diagnoses and reducing costs for hospitals and diagnostic labs adopting advanced sequencing technologies.EN

Researchers discovered that a single protein, angiopoietin-2, prevents blood vessels in the brain from leaking and developing abnormal structures. The finding could explain how certain brain disorders develop and point toward new drug targets for conditions ranging from stroke recovery to neurodegeneration.EN

Researchers have developed two radioactive imaging agents that can detect gastrin-releasing peptide receptors, markers present in several aggressive cancers including prostate and breast tumors. The agents cleared quickly from the bloodstream while accumulating strongly in tumors, suggesting they could improve early diagnosis and enable better patient stratification for precision therapies.EN

Researchers used high-frequency ultrasound to visualize structural changes in epidermolysis bullosa, a rare genetic blistering disorder. The imaging technique could enable earlier diagnosis and track disease progression without invasive biopsies, potentially reducing treatment delays and improving outcomes for patients with this debilitating condition.EN

Researchers found that repeated moderate hypothermia causes lasting damage to the brain's glymphatic system—the network that clears toxic proteins—even after body temperature returns to normal. The damage involves loss of a critical water channel protein. The finding raises concerns for patients undergoing repeated cold therapies and suggests new vulnerabilities in neurodegenerative disease risk.EN

Researchers have developed upSPLAT, a library preparation technique that slashes the cost of preparing DNA samples for sequencing by roughly tenfold. The breakthrough addresses a major bottleneck in genomics research and could enable large-scale population studies, disease screening programs, and clinical diagnostics that were previously too expensive to execute.EN

A Swedish study of 3,747 triple-negative breast cancer patients found that giving chemotherapy before surgery versus after surgery produced nearly identical survival rates. The finding challenges the growing preference for upfront chemotherapy and could shift treatment protocols and drug development priorities for this difficult-to-treat cancer type.EN

Researchers have identified potential direct interactions between two protein families that regulate chloride channels in cells—a discovery that could reshape drug development for inflammatory and pain conditions. The finding opens new therapeutic targets, particularly in cardiovascular disease, though scientists say much more testing is needed across other tissues.EN

Researchers directly recorded brain activity in three patients and found that the motor cortex activates during passive touch, even without movement. The discovery reshapes how neuroscientists understand sensory-motor integration and could inform development of better prosthetics, robotic control systems, and treatments for neurological injuries.EN

Researchers have created the first comprehensive atlas of cochlear structure using advanced imaging of 100 healthy human ears. The detailed measurements could improve surgical planning, hearing aid design, and cochlear implant outcomes—opening new commercial opportunities in audiology and otologic device development.EN

Researchers have discovered that successful bacterial colonization of the gut depends on a combination of toxin-delivery weapons, metabolic flexibility, and luck—findings that could reshape how scientists think about probiotic design and microbiome stability. The work suggests that simply introducing beneficial bacteria won't work unless they can outcompete residents through multiple, coordinated mechanisms.EN

A new study challenges the assumption that individual differences in digestion speed are driven by microbiota composition. Researchers transplanted gut bacteria from donors with different transit times into germ-free mice and found no effect on recipient digestion rates—suggesting other biological factors, not bacterial makeup, control this trait. The finding could reshape how companies approach microbiota-based therapeutics and personalized medicine strategies.EN

Researchers have mapped the plasmid genes—extra-chromosomal DNA fragments—that Lyme bacteria carry, revealing dramatic variation that could explain why some strains cause worse disease than others. The findings open a path to predicting which Lyme variants pose the greatest public health risk and could reshape how clinicians and public health officials respond to regional outbreaks.EN

Chilean salmon producers rely heavily on antibiotics to fight a persistent fish disease, creating ideal conditions for drug-resistant bacteria that threaten both food safety and human health. Researchers say current farming practices and weak vaccines leave the industry trapped in a cycle of overuse with no immediate solution.EN

Researchers have developed a genomic prediction method that dramatically improves wheat breeding by accounting for how plants respond differently to varying weather conditions. The technique could accelerate crop development cycles and help breeders select better varieties faster, reducing time-to-market for improved wheat varieties.EN

A genetic analysis of Finnish wolves reveals declining diversity and rising inbreeding over two decades, with the population split into isolated subgroups that cannot sustain themselves under current conditions. The findings challenge how European nations manage protected wolf populations under EU law and could reshape conservation policy across Scandinavia.EN

A new analysis of patient experiences with leniolisib, a treatment for ultra-rare activated PI3Kδ syndrome, found that 86% of patients reported meaningful improvements in daily life—not just lab markers. The findings suggest a broader market opportunity for precision immunotherapies targeting rare genetic disorders, and demonstrate the commercial value of capturing patient-reported outcomes early in drug development.EN

Researchers have mapped the epigenetic mechanisms—chemical tags on DNA that silence crucial genes—that allow multiple myeloma cells to survive current treatments. The findings identify specific protein machines as drug targets, potentially breaking the treatment resistance that limits survival gains for the thousands diagnosed annually.EN

Researchers have developed a microscopic electrode that can measure acetylcholine release from individual brain cells with unprecedented precision, capturing activity at the molecular level. The breakthrough could accelerate drug development for neurological diseases and cognitive disorders by enabling researchers to directly observe how cells communicate—a process previously too fast and chemically invisible to measure reliably.EN

Researchers discovered lysozyme alongside transthyretin amyloid in the spinal ligaments of patients with lumbar stenosis. While the proteins don't interact, lysozyme actually slows transthyretin fiber formation—a finding that could reshape understanding of age-related spine disease and inform drug development strategies targeting amyloid-driven disorders.EN